Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuma Irie

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Scientific Reports|January 12, 2021
Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimensYukie Kashima, Yosuke Togashi, Shota Fukuoka, et al.
JCI Insight|April 7, 2022
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancerKentaro Masuhiro, Motohiro Tamiya, Kosuke Fujimoto, et al.
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
Science Immunology|November 12, 2021
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escapeYoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, et al.
Nature Cancer|February 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)Hideaki Bando, Shogo Kumagai, Daisuke Kotani, et al.
Nature Immunology|September 2, 2020
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
Nature|July 14, 2025
Microbiota-driven antitumour immunity mediated by dendritic cell migrationNina Yi-Tzu Lin, Shota Fukuoka, Shohei Koyama, et al.
Cancer Cell|January 29, 2022
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironmentsShogo Kumagai, Shohei Koyama, Kota Itahashi, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Scientific Reports|January 12, 2021
Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimensYukie Kashima, Yosuke Togashi, Shota Fukuoka, et al.
JCI Insight|April 7, 2022
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancerKentaro Masuhiro, Motohiro Tamiya, Kosuke Fujimoto, et al.
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
Science Immunology|November 12, 2021
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escapeYoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, et al.
Nature Cancer|February 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)Hideaki Bando, Shogo Kumagai, Daisuke Kotani, et al.
Nature Immunology|September 2, 2020
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
Nature|July 14, 2025
Microbiota-driven antitumour immunity mediated by dendritic cell migrationNina Yi-Tzu Lin, Shota Fukuoka, Shohei Koyama, et al.
Cancer Cell|January 29, 2022
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironmentsShogo Kumagai, Shohei Koyama, Kota Itahashi, et al.
Pageof 3